-+ 0.00%
-+ 0.00%
-+ 0.00%

Contineum CSO Daniel S. Lorrain sells USD 54,741 in common shares

PUBT·05/01/2026 21:43:26
Listen to the news
Contineum CSO Daniel S. Lorrain sells USD 54,741 in common shares
  • Contineum Therapeutics Chief Scientific Officer Daniel S. Lorrain sold 4,170 shares of Class A common stock on May 1, 2026.
  • Sales were reported at weighted average prices of $13.06 and $13.84.
  • Lorrain reported 143,542 shares owned directly following transactions.
  • Filing also showed 6,842 shares held indirectly by spouse.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Contineum Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-029435), on May 01, 2026, and is solely responsible for the information contained therein.